Order of the Supreme Court of India in the matter of Network of People Living With HIV/AIDS & Others Vs Union of India & Others dated 24/02/2025. The Supreme Court (SC), February 24, 2025 has directed all states to file their affidavits addressing concerns raised about antiretroviral therapy (ART) drugs …
It was the most expensive foreign acquisition by an Indian company in 2006. Dr Reddy’s Laboratories had gone to town with its trophy, German branded generics company Betapharm, acquired for $560 million (Rs 2,550 crore). Six years later, the valuation of Betapharm in the company’s balance sheet is just $108 …
Intra-abdominal infections are common in young infants and lead to significant morbidity and mortality. Meropenem is a broad-spectrum antimicrobial with excellent activity against pathogens associated with intra-abdominal infections. The purpose of this study was to determine the safety and effectiveness of meropenem in young infants with suspected or complicated intra-abdominal …
London: Scientists have developed a new drug which they claim can put cancerous cells to sleep to stop them from multiplying. The drug called Aflibercept tricks tumours into becoming dormant by flipping molecular switches in the structure of the cancer so it cannot spread. Positive results are being seen already …
Accepts GoM's final recommendations without changes, say sources The Cabinet today endorsed the recommendations of a Group of Ministers’ (GoM) on a revised National Pharmaceutical Pricing Policy, giving shape to a long-pending issue. The government did not give out details of the decision. According to sources, the Cabinet has imposed …
Just in the nick of time, the Government has cobbled together a consensus on the proposed National Pharmaceutical Pricing Policy. Side-stepping debates on whether to go with a cost-of-production based formula or a market-price based method – the Government now looks to cap medicine prices at the “simple average” of …
The Central Government on Wednesday said it had resolved all issues concerning the drug pricing policy and would finalise its stand before November 27, the deadline set by the Supreme Court. A Group of Ministers (GoM) headed by Agriculture Minister Sharad Pawar on Wednesday met to discuss the issues. “We …
Europe is set to quash a precedent-setting initiative designed to tackle a disturbing side effect of common drugs — their impact on aquatic life. Nature has learned that landmark regulations intended to clean Europe’s waterways of pharmaceuticals are likely to be dead on arrival when they reach a key vote …
GoM to keep market-based pricing mechanism but will tweak method used for calculating price increase The ministerial panel entrusted with framing the country’s drug pricing guidelines will meet Finance Minister P Chidambaram on Wednesday to discuss its final draft policy. The Group of Ministers, led by Agriculture Minister Sharad Pawar, …
The company’s recently acquired plant in Ratnagiri is set to attract investments of Rs 80 crore Omkar Speciality Chemicals Ltd, a leading specialty chemical manufacturer with about 80 diversified products in its portfolio, has chalked out Rs 150 crore capital expenditure for the next 18 months, to increase its production …
Two new drugs to treat drug-resistant TB are expected to hit the market in 2013. The drugs, Bedaqiline (TMC207) and Delamanid (OPC6783) are practically the first drugs to be developed in nearly 50 years and are expected to improve treatment of DR-TB. These two investigational TB drugs are entering phase …
Publicly-held biotechnology major Biocon Ltd on Friday announced it had entered into an agreement with the US-based $21-billion Bristol-Myers Squibb (BMS) to further develop its IN-105, an oral insulin product candidate. Biocon will use BMS’ expertise in clinical trials and get help in redesigning Phase-II trials of the blockbuster drug. …
Chidambaram to be special invitee at Friday?s review meeting SC wants clear policy by November 27 hearing The long-pending pharmaceutical pricing policy revamp, awaiting Cabinet approval, has been sent back to the group of ministers (GoM) which finalised it. The prime minister’s office (PMO) wants the GoM to address concerns …
In a big relief to generic drug major Cipla, the Supreme Court has stayed the Delhi High Court’s order that restrained the Indian company from marketing generic version of its anti-cancer drug Sunitinib, which is being developed by US pharmaceutical firms Sugen and Pharmacia & Upjohn Company. The Indian drug …
New Delhi In a big relief to generic drug major Cipla, the Supreme Court has stayed the Delhi High Court’s order that restrained the Indian company from marketing generic version of its anti-cancer drug Sunitinib, which is being developed by US pharmaceutical firms Sugen and Pharmacia & Upjohn Company. The …
LUCKNOW: Central Drug Research Institute, Lucknow has developed a drug - 'Novel Bone Anabolic Agents' for accelerated healing of fractures by stimulating bone formation. The institute has also recently entered into an exclusive licence agreement with an US-based firm for further production and development. These naturally occurring anabolic agents were …
Populations of oriental white-backed vulture (Gyps bengalensis), long-billed vulture (Gyps indicus) and slender-billed vulture (Gyps tenuirostris) crashed during the mid-1990s throughout the Indian subcontinent. Surveys in India, initially conducted in 1991–1993 and repeated in 2000, 2002, 2003 and 2007, revealed that the population of Gyps bengalensis had fallen by 2007 …
Batches of the world’s first vaccine against the hepatitis E virus began rolling out of a Chinese factory, promising to stem a disease that every year infects about 20 million people and claims 70,000 lives. The vaccine is being hailed as a victory for an unusual public–private partnership that could …
New Delhi The laxness in branding medicines, a common practice for long but with serious implications for public health besides being an unhealthy business practice, might soon end. A recent health ministry move to bar state drug regulators from granting manufacturing licences on brand names may force companies to queue …
Mumbai Stung by widespread criticism of alleged lax standards in conducting clinical trials in the country, clinical research organisations (CROs), which conduct human drug trials on behalf of pharma companies, have resorted to technology to make the process more transparent. For the first time in India, some CROs and a …
Govt move aimed at making drugs affordable, tackling issues of trademark violations The lobby group Indian Drugs Manufacturing Association will take a call on legal action in its meeting on Friday after a new directive by the health minister banned firms from using brand names while applying for a manufacturing …
